Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

Clinical trial NCT06219174 · SUSPENDED

Trial details

NCT number: NCT06219174
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Lung Cancer

Start date: 2024-08-07
Primary completion: 2029-08-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.